Figure 4. Summary of the Molecular Profiling of Patients in Fusion, Other, and Tumor Suppression Gene Category.

Data were derived from all 62 patients with completed whole-exome sequencing as well as RNA sequencing of tumors and whole-exome sequencing of germline DNA. The presence of specific mutations, insertion/deletions (indels), amplification/deletions, and genes fusions are indicated by colored circles for hematological malignant neoplasms and solid tumors. Only sequencing findings with biological significance are included. See the caption to Figure 3 for the types included in each neoplasm/tumor category and for the color key.